These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11217146)

  • 1. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
    Gulesserian T; Seidl R; Hardmeier R; Cairns N; Lubec G
    J Investig Med; 2001 Jan; 49(1):41-6. PubMed ID: 11217146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.
    Percy ME; Dalton AJ; Markovic VD; McLachlan DR; Hummel JT; Rusk AC; Andrews DF
    Am J Med Genet; 1990 Apr; 35(4):459-67. PubMed ID: 2139757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.
    Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
    J Neural Transm Suppl; 2001; (61):71-84. PubMed ID: 11771762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and mitochondrial dysfunction in Down syndrome.
    Pagano G; Castello G
    Adv Exp Med Biol; 2012; 724():291-9. PubMed ID: 22411251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil oxidative metabolism in Down syndrome patients with congenital heart defects.
    Akinci O; Mihci E; Tacoy S; Kardelen F; Keser I; Aslan M
    Environ Mol Mutagen; 2010 Jan; 51(1):57-63. PubMed ID: 19593803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes.
    Sebastià J; Cristòfol R; Pertusa M; Vílchez D; Torán N; Barambio S; Rodríguez-Farré E; Sanfeliu C
    Eur J Neurosci; 2004 Nov; 20(9):2355-66. PubMed ID: 15525277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized SOD1 alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice.
    Le Pecheur M; Bourdon E; Paly E; Farout L; Friguet B; London J
    FEBS Lett; 2005 Jul; 579(17):3613-8. PubMed ID: 15961078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased superoxide dismutase and Down's syndrome.
    Turrens JF
    Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oxidant gene expression imbalance, aging and Down syndrome.
    Sinha S
    Life Sci; 2005 Feb; 76(12):1407-26. PubMed ID: 15670619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of copper-zinc superoxide dismutase in trisomy 21.
    De La Torre R; Casado A; López-Fernández E; Carrascosa D; Ramírez V; Sáez J
    Experientia; 1996 Sep; 52(9):871-3. PubMed ID: 8841514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome analysis in hippocampus of mice overexpressing human Cu/Zn-superoxide dismutase 1.
    Shin JH; London J; Le Pecheur M; Weitzdoerfer R; Hoeger H; Lubec G
    Neurochem Int; 2005 Jun; 46(8):641-53. PubMed ID: 15863242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts.
    Annerén KG; Epstein CJ
    Pediatr Res; 1987 Jan; 21(1):88-92. PubMed ID: 2948148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.
    Laddha NC; Dwivedi M; Gani AR; Shajil EM; Begum R
    Free Radic Biol Med; 2013 Dec; 65():1110-1125. PubMed ID: 24036105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders.
    Krapfenbauer K; Engidawork E; Cairns N; Fountoulakis M; Lubec G
    Brain Res; 2003 Mar; 967(1-2):152-60. PubMed ID: 12650976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury.
    Wheeler MD; Katuna M; Smutney OM; Froh M; Dikalova A; Mason RP; Samulski RJ; Thurman RG
    Hum Gene Ther; 2001 Dec; 12(18):2167-77. PubMed ID: 11779401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
    Ceballos-Picot I
    C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.
    Parisotto EB; Garlet TR; Cavalli VL; Zamoner A; da Rosa JS; Bastos J; Micke GA; Fröde TS; Pedrosa RC; Wilhelm Filho D
    Res Dev Disabil; 2014 Jun; 35(6):1228-36. PubMed ID: 24685938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the "gene dosage effect" hypothesis.
    de Haan JB; Susil B; Pritchard M; Kola I
    J Neural Transm Suppl; 2003; (67):67-83. PubMed ID: 15068240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
    Vlkolinský R; Cairns N; Fountoulakis M; Lubec G
    Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.